Insmed CEO to Present at Drug Discovery & Development Conference
redorbit.com     Jul 25, 2008            

Posted on: Friday, 25 July 2008, 09:01 CDT RICHMOND, Va., July 25 /PRNewswire-FirstCall/ -- Insmed Inc. a developer of follow-on biologics and biopharmaceuticals, today announced that Geoffrey Allan, Ph.D., CEO of Insmed, will present at IBC's 13th Annual Drug Discovery and Development of Innovative Therapeutics on Thursday, August 7th, 2008 at 9:25 AM ET. Dr. Allan will be participating in the Orphan Diseases track of the conference and his presentation will be entitled, "Myotonic Muscular Dystrophy - A Major Unmet Medical Need." He will present Insmed's progress with its Phase II trial for IPLEX(TM) in Myotonic Muscular Dystrophy. The trial, which has seen strong patient and physician interest, is now fully enrolled. It is a six month, randomized, double-blind, placebo-controlled trial being conducted at 13 research centers... [read full story]                    


View all news articles about*:
America Biopharmaceuticals Birth Boston CEO Child Defects Discoveries Dystrophy General Genetics Health Insmed Issues Management Massachusetts Medicines Muscular North Pharmaceuticals Remedies Richmond Scientific Senior States United Virginia
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Mipcom books Wang for keynote

variety.com     31 mins ago          

TV programming mart runs Oct. 13-17 SEOUL -- Gary Wang, founder and CEO of Tudou, China's leading video-sharing platform, will deliver a keynote at the upcoming Mipcom. The TV programming mart runs Oct. 13-17 in Cannes....                    

comments

                   

The new China price

startribune.com     44 mins ago          

Marlin Levison, Star Tribune A freighter makes its way towards Duluth harbor to pick up a load of cargo. Exxel Outdoors CEO Harry Kazazian said his company made 70 percent of its sleeping bags in China in 2005. Exxel,...                    

comments

                   

Scientists reveal changes to embryonic stem cells caused by Down syndrome

genengnews.com     Sep 4, 2008   2 related          

EUREKALERT Contact: Alex Fernandes a.fernandes@qmul.ac.uk Queen Mary, University of London Scientists investigating the mechanisms of Down Syndrome (DS) have revealed the earliest developmental changes in embryonic stem...                    

comments

                   

Action Duchenne Funds £200k For New Research For A Cure For Duchenne Muscular Dystrophy

medicalnewstoday.com     Sep 4, 2008          

New research project focuses on stem cell research to counter effects of muscle-wasting disease that affects boys and young men Action Duchenne is funding a £200k research project into Stem Cell research undertaken by...                    

comments